This announcement is a separate document:
共同药业:关于2024年第二季度可转换公司债券转股情况的公告
Hubei Goto Biopharm: Announcement on the conversion of convertible corporate bonds to stocks in Q2 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.